Patents Assigned to Surromed, Inc.
  • Patent number: 6982154
    Abstract: Sickle-cell diseases are treated with annexin proteins that are modified to increase their half-life in the circulation.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: January 3, 2006
    Assignee: Surromed, Inc.
    Inventor: Anthony Allison
  • Patent number: 6924114
    Abstract: The amount of platelet surface proteins in a sample may be measured by collecting a sample containing platelets into a collection tube containing a platelet stabilizing composition, labeling the platelet surface protein and detecting by cytometry.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: August 2, 2005
    Assignee: SurroMed, Inc.
    Inventors: Timothy L. Wyant, Paul A. Raju, Aaron B. Kantor
  • Publication number: 20050158870
    Abstract: Surface-enhanced Raman spectroscopy (SERS) uses nanoscale metal particles (SERS-active particles) or surface roughness to enhance the Raman signal of Raman-active analytes contacting the surface. SERS sandwich particles contain SERS-active particles sandwiching a Raman-active substance and serve as optical tags. Preferably, the particles are rod-shaped, with each layer (SERS-active and Raman-active) formed as a distinct stripe of the particle. These freestanding particles can be derivatized with surface ligands capable of associating with analytes of interest in, for example, a biological sample. The acquired Raman spectrum of the particle encodes the identity of the ligand. Because of the simplicity and intensity of Raman spectra, highly multiplexed assays are capable using SERS particles with different Raman-active species.
    Type: Application
    Filed: February 4, 2005
    Publication date: July 21, 2005
    Applicant: SURROMED, INC.
    Inventor: Michael Natan
  • Publication number: 20050116159
    Abstract: Relative quantitative information about components of chemical or biological samples can be obtained from mass spectra by normalizing the spectra to yield peak intensity values that accurately reflect concentrations of the responsible species. A normalization factor is computed from peak intensities of those inherent components whose concentration remains constant across a series of samples. Relative concentrations of a component occurring in different samples can be estimated from the normalized peak intensities. Unlike conventional methods, internal standards or additional reagents are not required. The methods are particularly useful for differential phenotyping in proteomics and metabolomics research, in which molecules varying in concentration across samples are identified. These identified species may serve as biological markers for disease or response to therapy.
    Type: Application
    Filed: December 27, 2004
    Publication date: June 2, 2005
    Applicant: SurroMed, Inc.
    Inventors: Christopher Becker, Curtis Hastings, Scott Norton, Sushmita Roy, Weixun Wang, Haihong Zhou, Thomas Shaler, Praveen Kumar, Markus Anderle, Hua Lin
  • Publication number: 20050109928
    Abstract: High-intensity, spiked noise is reduced in chromatography-mass spectrometry data by applying a nonlinear filter such as a moving median filter to the data. The filter is applied to individual mass chromatograms, plots of ion abundance versus retention time for each detected mass-to-charge ratio, and the filtered chromatograms are combined to form a filtered total ion current chromatogram. Standard linear filters are not effective for reducing noise in liquid chromatography-mass spectrometry (LC-MS) data because they assume a normal distribution of noise. LC-MS noise, however, is not normally distributed.
    Type: Application
    Filed: September 7, 2004
    Publication date: May 26, 2005
    Applicant: SURROMED, INC.
    Inventor: Curtis Hastings
  • Patent number: 6873915
    Abstract: An automatic peak selection method for multidimensional data that selects peaks from very noisy data such as two-dimensional liquid chromatography-mass spectrometry (LC-MS) data is described. Such data are characterized by non-normally distributed noise that varies in different dimensions. The method computes local noise thresholds for each one-dimensional component of the data. Each point has a local noise threshold applied to it for each dimension of the data set, and a point is selected as a candidate peak only if its value exceeds all of the applied local noise thresholds. Contiguous candidate peaks are clustered into actual peaks. The method is preferably implemented as part of a high-throughput platform for analyzing complex biological mixtures.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: March 29, 2005
    Assignee: Surromed, Inc.
    Inventor: Curtis A. Hastings
  • Publication number: 20050057749
    Abstract: Methods and instrumentation for performing charge coupled device (CCD)-based confocal spectroscopy with a laser spot array are provided. The methods and instruments of the invention are useful in any spectroscopic application, including, but not limited to, microscopy and microvolume laser scanning cytometry (MLSC).
    Type: Application
    Filed: October 5, 2004
    Publication date: March 17, 2005
    Applicant: SURROMED, INC.
    Inventors: Louis Dietz, Ian Walton, Scott Norton
  • Patent number: 6861263
    Abstract: Surface-enhanced Raman spectroscopy (SERS) uses nanoscale metal particles (SERS-active particles) or surface roughness to enhance the Raman signal of Raman-active analytes contacting the surface. SERS sandwich particles contain SERS-active particles sandwiching a Raman-active substance and serve as optical tags. Preferably, the particles are rod-shaped, with each layer (SERS-active and Raman-active) formed as a distinct stripe of the particle. These freestanding particles can be derivatized with surface ligands capable of associating with analytes of interest in, for example, a biological sample. The acquired Raman spectrum of the particle encodes the identity of the ligand. Because of the simplicity and intensity of Raman spectra, highly multiplexed assays are capable using SERS particles with different Raman-active species.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: March 1, 2005
    Assignee: Surromed, Inc.
    Inventor: Michael J. Natan
  • Patent number: 6835927
    Abstract: Relative quantitative information about components of chemical or biological samples can be obtained from mass spectra by normalizing the spectra to yield peak intensity values that accurately reflect concentrations of the responsible species. A normalization factor is computed from peak intensities of those inherent components whose concentration remains constant across a series of samples. Relative concentrations of a component occurring in different samples can be estimated from the normalized peak intensities. Unlike conventional methods, internal standards or additional reagents are not required. The methods are particularly useful for differential phenotyping in proteomics and metabolomics research, in which molecules varying in concentration across samples are identified. These identified species may serve as biological markers for disease or response to therapy.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: December 28, 2004
    Assignee: Surromed, Inc.
    Inventors: Christopher H. Becker, Curtis A. Hastings, Scott M. Norton
  • Publication number: 20040209376
    Abstract: Freestanding particles comprising a plurality of segments, wherein the particle length is from 10 nm to 50 &mgr;m and the particle width is form 5 nm to 50 &mgr;m.
    Type: Application
    Filed: May 6, 2004
    Publication date: October 21, 2004
    Applicant: SURROMED, INC.
    Inventors: Michael J. Natan, Thomas E. Mallouk
  • Patent number: 6800860
    Abstract: Methods and instrumentation for performing charge coupled device (CCD)-based confocal spectroscopy with a laser spot array are provided. The methods and instruments of the invention are useful in any spectroscopic application, including, but not limited to, microscopy and microvolume laser scanning cytometry (MLSC).
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: October 5, 2004
    Assignee: SurroMed, Inc.
    Inventors: Louis J. Dietz, Ian Walton, Scott Norton
  • Patent number: 6800490
    Abstract: Multiplexed assays may be performed using extraction probe comprised of solid supports and extraction phases.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: October 5, 2004
    Assignee: Surromed, Inc.
    Inventors: Michael J. Nathan, Rajendra Singh, Remy Cromer
  • Patent number: 6787761
    Abstract: High-intensity, spiked noise is reduced in chromatography-mass spectrometry data by applying a nonlinear filter such as a moving median filter to the data. The filter is applied to individual mass chromatograms, plots of ion abundance versus retention time for each detected mass-to-charge ratio, and the filtered chromatograms are combined to form a filtered total ion current chromatogram. Standard linear filters are not effective for reducing noise in liquid chromatography-mass spectrometry (LC-MS) data because they assume a normal distribution of noise. LC-MS noise, however, is not normally distributed.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: September 7, 2004
    Assignee: Surromed, Inc.
    Inventor: Curtis Hastings
  • Patent number: 6780301
    Abstract: Synthetic methods for the manufacture of segmented nanoparticles are described.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: August 24, 2004
    Assignee: Surromed, Inc.
    Inventors: Michael J. Natan, Thomas E. Mallouk, Benjamin R. Martin, Brian D. Reiss, Louis J. Dietz, James L. Winkler
  • Patent number: 6753135
    Abstract: Novel biological markers indicative of the action of an anti-inflammatory or immunosuppressive drug can be used to evaluate drug efficacy and compare local and systemic drug effects. They can also aid in comparison of different drugs, doses, and delivery routes. The biological markers include cell populations, cell surface antigen expression levels, and soluble factor concentrations. Measurement values of the novel biomarkers were shown to change significantly in allergic, atopic asthmatic, and healthy subjects after administration of prednisone.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: June 22, 2004
    Assignee: SurroMed, Inc.
    Inventors: Susan E. Alters, Karen L. Cheal, Aaron B. Kantor
  • Publication number: 20040113062
    Abstract: Nonlinear retention time variations in chromatography-mass spectrometry data sets are adjusted by time-alignment methods, enabling automated comparison of spectra for differential phenotyping and other applications.
    Type: Application
    Filed: May 9, 2003
    Publication date: June 17, 2004
    Applicant: SurroMed, Inc.
    Inventor: Scott M. Norton
  • Publication number: 20040086515
    Abstract: Sickle-cell diseases are treated with annexin proteins that are modified to increase their half-life in the circulation.
    Type: Application
    Filed: August 1, 2003
    Publication date: May 6, 2004
    Applicant: SurroMed, Inc.
    Inventor: Anthony Allison
  • Patent number: 6687395
    Abstract: The present invention provides an improved integrated system for biological marker identification. The system uses Microvolume Laser Scanning Microscopy (MLSC) in order to measure patterns of expression of biological markers in biological fluids. The system includes improved instrumentation for performing MLSC, and also includes improved particle detection and analysis methods. The system further comprises an informatics architecture for the analysis of data obtained from the MLSC in tandem with other medical information.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: February 3, 2004
    Assignee: SurroMed, Inc.
    Inventors: Louis J. Dietz, Ian Walton, Chih-Hua Chung, Scott Norton, James L. Winkler, Aaron B. Kantor, Byron Lee, Shalom Tsur
  • Publication number: 20030233035
    Abstract: Choroid plexus failure in a subject is diagnosed and treated by measuring the level of one or more components of cerebrospinal fluid, comparing the level to a desired level, and adjusting the level toward the desired level. Treatment can occur using an implantable device.
    Type: Application
    Filed: June 12, 2003
    Publication date: December 18, 2003
    Applicant: SurroMed, Inc.
    Inventor: Edward Rubenstein
  • Publication number: 20030228263
    Abstract: Methods and pharmaceutical compositions containing the organic germanium polymer propagermanium are used for treating bone disorders such as myeloma bone disease, multiple myeloma, Paget's disease, secondary bone cancers, and periodontitis.
    Type: Application
    Filed: April 10, 2003
    Publication date: December 11, 2003
    Applicant: SurroMed, Inc.
    Inventor: Anthony Allison